dioxadet has been researched along with Cancer of Ovary in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aleksandrov, VA; Aristova, VA; Beliaev, AM; Beliaeva, OA; Bespalov, VG; Ivantsov, AO; Kireeva, GS; Maĭdin, MA; Semënov, AL; Senchik, KIu; Stukov, AN; Vyshinskaia, EA | 1 |
| Aleksandrov, VA; Aristova, VA; Beliaev, AM; Beliaeva, OA; Bespalov, VG; Kireeva, GS; Kon'kov, SA; Krylova, IA; Maĭdin, MA; Semënov, AL; Senchik, KIu; Stukov, AN; Vyshinskaia, EA | 1 |
| Belyaev, AM; Belyaeva, OA; Bespalov, VG; Gafton, GI; Guseynov, KD; Kireeva, GS; Maydin, MA; Semenov, AL; Senchik, KY; Stukov, AN | 1 |
| Alexandrov, VA; Belyaev, AM; Belyaeva, OA; Bespalov, VG; Kireeva, GS; Kopteva, OS; Krasilnikova, LA; Maidin, MA; Semenov, AL; Stukov, AN; Vasilieva, IN; Vyshinskaya, EA | 1 |
| Alexeev, VV; Belyaev, AM; Belyaeva, OA; Bespalov, VG; Gafton, GI; Guseinov, KD; Kireeva, GS; Senchik, KY; Soloviev, LA; Stukov, AN; Vasilchenko, MV | 1 |
| Belyaev, AM; Belyaeva, OA; Bespalov, VG; Gafton, GI; Guseynov, KD; Kalinin, OE; Kireeva, GS; Senchik, KY; Stukov, AN | 1 |
| Barakova, NV; Bespalov, VG; Maidin, MA; Semenov, AL; Stukov, AN; Vasil'eva, IN; Vyshinskaya, EA | 1 |
| Beliaeva, OA; Bespalov, VG; Gershanovich, ML; Kil'maeva, NE; Kon'kov, SA; Krylova, IM; Latipova, DKh; Mironiuk, TA; Murazov, IaG; Panchenko, AV; Stukov, AN | 1 |
| Dzhilavian, GA; Vinokurov, VL | 1 |
| Kraĭz, BO; Tret'iakov, AV | 1 |
10 other study(ies) available for dioxadet and Cancer of Ovary
| Article | Year |
|---|---|
[Experimental technology of chemoperfusion treatment for abdominal carcinomatosis in ovarian cancer].
Topics: Abdominal Neoplasms; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Female; Hyperthermia, Induced; Neoplasms, Experimental; Ovarian Neoplasms; Pelvis; Rats; Rats, Wistar; Triazines | 2014 |
[Antitumor effect of dioxadet in intraperitoneal chemoperfusion treatment for advanced ovarian cancer in experimental setting].
Topics: Animals; Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Female; Hyperthermia, Induced; Infusions, Parenteral; Neoplasms, Experimental; Ovarian Neoplasms; Rats; Rats, Wistar; Survival Analysis; Treatment Outcome; Triazines | 2014 |
Experimental study of antitumour activity and effects on leukocyte count of intraperitoneal administration and hyperthermic intraperitoneal chemoperfusion (HIPEC) with dioxadet in a rat model of ovarian cancer.
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Disease Models, Animal; Female; Hyperthermia, Induced; Infusions, Parenteral; Leukocyte Count; Leukocytes; Ovarian Neoplasms; Random Allocation; Rats; Rats, Wistar; Triazines | 2016 |
[Intraperitoneal chemotherapy--a method of improving treatment effectiveness in ovarian cancer].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Deoxycytidine; Female; Gemcitabine; Infusions, Intravenous; Infusions, Parenteral; Maximum Tolerated Dose; Melphalan; Mitomycin; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Rats; Rats, Wistar; Triazines | 2015 |
[Intraoperative intraperitoneal chemoperfusion treatment with cisplatin and dioxadet on a model of peritoneal carcinomatosis in ovarian cancer: safety and efficacy evaluation].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Female; Hyperthermia, Induced; Intraoperative Period; Ovarian Neoplasms; Peritoneal Cavity; Peritoneal Neoplasms; Rats; Rats, Wistar; Survival Analysis; Triazines | 2015 |
Both heat and new chemotherapeutic drug dioxadet in hyperthermic intraperitoneal chemoperfusion improved survival in rat ovarian cancer model.
Topics: Animals; Antineoplastic Agents, Alkylating; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Combined Modality Therapy; Disease Models, Animal; Female; Hyperthermia, Induced; Infusions, Parenteral; Ovarian Neoplasms; Random Allocation; Rats; Triazines | 2016 |
Comparative Study of Antitumor Efficiency of Intraperitoneal and Intravenous Cytostatics in Experimental Rats with Disseminated Ovarian Cancer.
Topics: Adenocarcinoma, Papillary; Animals; Antineoplastic Agents; Ascites; Cisplatin; Female; Injections, Intraperitoneal; Injections, Intravenous; Melphalan; Mitomycin; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Rats; Survival Analysis; Treatment Outcome; Triazines | 2017 |
[Antitumor activity of dioxadet compared with cisplatin on ascitic ovarian tumor in rats].
Topics: Animals; Antineoplastic Agents; Ascites; Cisplatin; Female; Ovarian Neoplasms; Rats; Rats, Wistar; Treatment Outcome; Triazines | 2011 |
[The effect of various factors on the results of chemotherapy in patients with recurrent ovarian serous cystadenocarcinoma].
Topics: Antineoplastic Agents; Combined Modality Therapy; Cyclophosphamide; Cystadenocarcinoma; Female; Humans; Melphalan; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prognosis; Thiotepa; Time Factors; Triazines | 1984 |
[Potentiation of the antitumor activity of dioxadet by antiestrogen para-aminobenzhydrazide in a model of ovarian ascites tumor].
Topics: Aniline Compounds; Animals; Antineoplastic Agents; Ascites; Disease Models, Animal; Drug Synergism; Female; Ovarian Neoplasms; Rats; Rats, Inbred Strains; Triazines | 1983 |